-
Signature
-
/s/ Latha Vairavan, as Attorney-in-Fact for Howard G. Welgus
-
Issuer symbol
-
ARQT
-
Transactions as of
-
01 Aug 2025
-
Transactions value $
-
-$142,982
-
Form type
-
4
-
Filing time
-
05 Aug 2025, 18:28:38
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Welgus Howard G. |
Director |
C/O ARCUTIS BIOTHERAPEUTICS, INC., 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE |
/s/ Latha Vairavan, as Attorney-in-Fact for Howard G. Welgus |
2025-08-05 |
0001801050 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ARQT |
Common Stock |
Options Exercise |
$0 |
+6.11K |
+6.1% |
$0.00 |
106K |
01 Aug 2025 |
Direct |
F1 |
| transaction |
ARQT |
Common Stock |
Sale |
-$87.4K |
-6.11K |
-5.75% |
$14.30 |
100K |
01 Aug 2025 |
Direct |
F1, F2 |
| transaction |
ARQT |
Common Stock |
Options Exercise |
$0 |
+3.89K |
+3.88% |
$0.00 |
104K |
01 Aug 2025 |
Direct |
F1 |
| transaction |
ARQT |
Common Stock |
Sale |
-$55.6K |
-3.89K |
-3.74% |
$14.30 |
100K |
01 Aug 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ARQT |
Stock Option (right to buy) |
Options Exercise |
$0 |
-6.11K |
-100% |
$0.00 |
0 |
01 Aug 2025 |
Common Stock |
6.11K |
$0.58 |
Direct |
F1, F3 |
| transaction |
ARQT |
Stock Option (right to buy) |
Options Exercise |
$0 |
-3.89K |
-100% |
$0.00 |
0 |
01 Aug 2025 |
Common Stock |
3.89K |
$1.68 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: